Physician profile
Steven Johnson
NPI 1881665560
$8,918.83
in general payments reported to CMS, 2019-2025
10 companies · $2,166 in 2025
The $2,166 reported for 2025 was more than what 80% of Surgical Critical Care providers received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $125 · 2021: $4,563 · 2022: $19.16 · 2023: $1,958 · 2024: $87.29 · 2025: $2,166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,000 · Travel and Lodging: $1,802 · Food and Beverage: $410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,000.00 |
| Travel and Lodging | $1,801.53 |
| Food and Beverage | $410.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,383.69 | 2021-2025 | Davinci Xi, Da Vinci Surgical System |
| Davol INC. | $161.56 | 2025 | Phasix Mesh |
| Takeda Pharmaceuticals U.S.A., INC. | $155.64 | 2020-2023 | Gattex |
| Abbvie INC. | $81.53 | 2024-2025 | |
| Vertex Pharmaceuticals Incorporated | $35.36 | 2025 | |
| Acera Surgical, INC. | $30.63 | 2024 | Restrata Wound Matrix |
| Integra Lifesciences Corporation | $19.13 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Mimedx Group, INC. | $18.55 | 2025 | |
| Novo Nordisk INC | $17.77 | 2024 | Wegovy |
| Lilly USA, LLC | $14.97 | 2024 | Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.